I-An Suen Email and Phone Number

Lead reporting and planning of novel Cell & Gene Therapy franchise

Directed financial function for a 500-FTE research site. Led cross-functional team of 60 to complete integration of ERP systems and financial reporting for legal entity merger within 3 months.

Managed monthly closing process for Alcon Germany and Austria. Turned around and stabilized the performance of team with 6 multi-national FTEs.

Partnered Ophtha business across 10+ Asian markets. Facilitated regional portfolio carve-out from Alcon and integration into Novartis.

Supported budgeting process and monthly closing reviews for 10 markets within Cluster

Rotated in Group Treasury / Financial Reporting / Business Planning and Analysis teams. Conducted credit rating analysis for strategic decisions, including M&A, USD 5 billion share buyback program, and USD 4 billion bond issuance. Assisted preparation of BoD presentation on Novartis Capital Structure and Allocation.

Assisted budget process and COGS management

Tutored elementary school students from disadvantaged family and helped them build up confidence and courage to face difficulties by designing a series of activities

Advised 22 individual clients, with an asset base totaling USD 3 million, on wealth management by conducting in-depth analyses of client profiles as well as economic outlook and by developing personalized financial plans

Performed business analyses and credit risk assessments of more than 200 SMEs and 150 large-cap corporations, allowing the bank to avoid USD 10 million potential loan default

Evaluated financial status of 8 investment target companies to assist managers in assessing possible investment risks and estimating investment returns